Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery

Outcomes of Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification

The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. This study aims to examine visual acuity and complication rates in femtosecond laser-assisted cataract surgery compared to traditional manual phacoemulsification cataract surgery for the beginning surgeon. In addition, this study will assess the subjective novice surgeon experience and the patient experience in terms of expectations and results.

Study Overview

Detailed Description

The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Cataract surgery training is a standard requirement of all ophthalmology residents who are part of this clinical study.

Each resident must be a post graduate year 4 (PGY-4) level resident before being asked to be a part of this clinical study. Typically, each resident will have completed approximately 30 cataract surgeries by their PGY-3 residency year of training. These traditional phacoemulsification require manual capsulorrhexis creation with which residents will have experience prior to study participation. Other critical manual surgical steps of traditional and femtosecond-laser assisted cataract surgery require similar surgical skill sets, thus residents should have surgical skills applicable to both techniques prior to study involvement.

In addition to performing 30 traditional phacoemulsification surgeries, residents also will have assisted with femtosecond laser-assisted cases during their PGY-3 training year training at the Dallas VA medical center and with staff at University of Texas (UT) Southwestern Medical Center during their cornea rotation. The femtosecond-assisted cases completed by each resident in the study at Parkland will be the Alcon Certification cases for each resident. Performing femtosecond-laser assisted cases at this level of training will provide objective insights into this new surgical technique in resident hands. Patients will not be subjected to any additional risk due to participation in this study as femtosecond laser Alcon Certification is already being performed by residents as part of their standard UT Southwestern ophthalmology training.

Patient eyes that meet the inclusion and exclusion criteria below will be randomly assigned to either the laser-assisted or the standard manual phacoemulsification group based. Following surgery, patients will return for post-operative visits at post-op day 1, post-op week 1, post-op month 1, and post-op month 3. Subjects will be followed in the Parkland Surgery Chief clinic. Subjects will not necessarily see the same study surgeon during each post-operative visit period. It should be noted this is the standard procedure as currently practiced in the Parkland ophthalmology clinic.

Verification of subject adherence to the post-operative follow-up visit schedule will be overseen by the PI throughout the course of the project. Weekly communication with sub-investigators will take place in order to review any outstanding concerns including recruitment effort, surgery schedules, and post-operative visit timelines. Arrangements for additional visits will also be reviewed and scheduled if medically necessary depending on individual patients' post-operative clinical course. Patients will be assigned to each group during the period of September 2015 through July 2016 and followed as part of the study for 3 months post-operatively.

Patients will be offered the same kerato-refractive procedures including manual limbal relaxing incisions or LenSx astigmatic keratotomy that would be offered to patients who are not part of this study. Patients will also be evaluated for benefit from advanced technology intraocular lenses (Toric for astigmatism and ReStor multifocal) that patients who are not part of the study would be offered. Offering advanced technology lenses or combined kerato-refractive procedures is not expected to influence the visual acuity study outcomes for patients in this study. Patient's clinical history, past medical history and ophthalmic medical notes (in particular pre-operative evaluation, operative, and post-operative follow up) will be reviewed. De-identified data points will be extracted for this project.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75235
        • Parkland Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Referred for cataract surgery at Parkland Memorial Hospital
  2. Potential post-operative visual acuity of 20/30 or greater determined by potential acuity meter (PAM) testing or modified super pinhole potential acuity of 20/30 or greater
  3. Clear intraocular media other than cataract in study eye(s)
  4. Subject eyes will have a dilated pupil diameter of at least 6 mm
  5. Subject eyes will lack other pre-existing ocular pathology or condition that may confound treatment effects, including diabetic retinopathy, previous retinal detachment, iris neovascularization, amblyopia, optic nerve atrophy or recurrent severe anterior or posterior segment inflammation of unknown etiology.

Exclusion Criteria:

  1. Severe corneal diseases or prior corneal surgery
  2. Active, significant external ocular or eyelid disease
  3. History of lens abnormalities including posterior polar cataract and zonular weakness precluding standard non-complex cataract surgery
  4. Retinal or posterior segment disease
  5. Advanced glaucoma, white or advanced cataract (precluding adequate examination of the posterior pole)
  6. Anatomic conditions that prevent placement of the femtosecond laser docking ring
  7. Corneal opacity that will interfere with the laser beam (hazy cornea)
  8. Presence of blood or materials in the anterior chamber
  9. Hypotony, advanced glaucoma, or presence of cornea implant
  10. Poor dilating pupil such that the iris is not peripheral to the intended diameter for the capsulotomy
  11. Condition which would cause inadequate clearance between the intended capsulotomy depth and the corneal endothelium
  12. Any contraindication to cataract or kerato-refractive surgery
  13. Contact lens wearers must discontinue the use of contacts for an appropriate period of time to ensure that their corneas are stable before screening measurements are performed. For rigid gas permeable (RGP) lenses, it is at least 2-4 weeks before accurate imaging measurements can be performed. Study doctor will assess patient findings and determine how long RGP lens wear must be discontinued prior to surgery. For soft contact lenses, it is at least 3 days prior to study measurements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LenSx
Laser-assisted cataract surgery performed using the LenSx femtosecond laser.
Experimental: Phaco
Traditional manual phacoemulsification cataract surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication rates
Time Frame: Operative visit to last post-op visit at 3 mos
Complication and adverse event monitoring will occur at each visit: pre-operative, operative, post-op day 1, post-op day 7-14, post-op day 30-60 and 3 mos post-op
Operative visit to last post-op visit at 3 mos
Visual Acuity
Time Frame: Change between baseline and 3 mos post-op.
Bilateral best spectacle corrected visual acuity
Change between baseline and 3 mos post-op.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient benefit perception
Time Frame: Post-op day 1
Patient perception of results assessed by questionnaire
Post-op day 1
Patient benefit perception
Time Frame: Post-op day 30-60
Patient perception of results assessed by questionnaire
Post-op day 30-60
Patient benefit perception
Time Frame: 3 mos post-op
Patient perception of results assessed by questionnaire
3 mos post-op
Corneal Endothelial Cell Count (ECC)
Time Frame: Change from baseline to post-op day 30-60

Specular micrography performed at baseline and post-op day 30-60 OR 3 month post-op* to measure change in ECC

*3 month ECC test will be done only if test was unable to be performed on post-op day 30-60 visit

Change from baseline to post-op day 30-60
Lens removal time
Time Frame: Operative visit
Comparison of time required for nuclear and cortex removal using the two techniques
Operative visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brock Hansen, M.D., University of Texas Southwestern Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2015

Primary Completion (Actual)

June 19, 2018

Study Completion (Actual)

June 19, 2018

Study Registration Dates

First Submitted

September 24, 2015

First Submitted That Met QC Criteria

September 24, 2015

First Posted (Estimate)

September 25, 2015

Study Record Updates

Last Update Posted (Actual)

May 21, 2020

Last Update Submitted That Met QC Criteria

May 19, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STU 092014-020

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incipient Cataract

Clinical Trials on Laser-assisted cataract surgery.

3
Subscribe